1. Thiourea derivatives induce fetal hemoglobin production in-vitro: A new class of potential therapeutic agents for β-thalassemia
   Hamad Ali et al, 2019, European Journal of Pharmacology CrossRef
2. Epigenetic and Transcriptional Modulator Potential of Epigallocatechin-3-gallate and Genistein on Fetal Hemoglobin Reactivators Genes
   Edna Ribeiro et al, 2022, Clinical Complementary Medicine and Pharmacology CrossRef
3. Plastrum Testudinis Extract Mitigates Thiram Toxicity in Broilers via Regulating PI3K/AKT Signaling
   Hammad Qamar et al, 2019, Biomolecules CrossRef
4. Exploring epigenetic and microRNA approaches for γ-globin gene regulation
   Athena Starlard-Davenport et al, 2021, Experimental Biology and Medicine CrossRef
5. Radix AstragaliStimulates p38 MARK Phosphorylation in Pediatric Patients withβ-Thalassemia
   Zhuoming Lu et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Recent trends for novel options in experimental biological therapy of β-thalassemia
   Alessia Finotti et al, 2014, Expert Opinion on Biological Therapy CrossRef
7. Molecular mechanisms of suberoylanilide hydroxamic acid in the inhibition of TGF‐β1‐mediated canine corneal fibrosis
   Kristina M. Gronkiewicz et al, 2016, Veterinary Ophthalmology CrossRef
8. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction
   Faisal Khan et al, 2020, Experimental Cell Research CrossRef